Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Cancer Research|July 23, 2003
A novel approach to cancer immunotherapy: tumor cells decorated with CD80 generate effective antitumor immunityNarendra P Singh, Esma S Yolcu, Douglas D Taylor, et al.
International Journal of Molecular Sciences|October 16, 2024
Establishment of Translational Luciferase-Based Cancer Models to Evaluate Antitumoral TherapiesMartin R Ramos-Gonzalez, Nagabhishek Sirpu Natesh, Satyanarayana Rachagani, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Immune Biomarkers of Islet Transplant Rejection Revealed by Synthetic Immunological NicheJyotirmoy Roy, Abdalmonam Jadou Nejma, Mohammad Tarique, et al.
ACS Nano|August 23, 2019
Rapid On-Demand Extracellular Vesicle Augmentation with Versatile Oligonucleotide TethersSaigopalakrishna S Yerneni, Sushil Lathwal, Pradeep Shrestha, et al.
ACS Applied Materials & Interfaces|December 19, 2022
Fas Ligand-Modified Scaffolds Protect Stem Cell Derived β-Cells by Modulating Immune Cell Numbers and PolarizationFeiran Li, Kelly Crumley, Elizabeth Bealer, et al.
Vaccines|March 28, 2024
Oncolytic Adenovirus Armed with a Novel Agonist of the CD137 Immune Checkpoint Stimulator Suppresses Tumor GrowthMartin R Ramos-Gonzalez, Mohammad Tarique, Lalit Batra, et al.
JCI Insight|March 17, 2026
Islets Co-engineered with Thrombomodulin and CD47 Achieve Sustained Survival in Allogeneic Recipients without Chronic ImmunosuppressionShadab Kazmi, Mohammad Tarique, Darshan Badal, et al.
Cancer Research|January 23, 2014
Fragmented sleep accelerates tumor growth and progression through recruitment of tumor-associated macrophages and TLR4 signalingFahed Hakim, Yang Wang, Shelley X L Zhang, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 19, 2019
Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilegeKyle B Woodward, Hong Zhao, Pradeep Shrestha, et al.
Cancer Research|February 17, 2019
A Novel Form of 4-1BBL Prevents Cancer Development via Nonspecific Activation of CD4+ T and Natural Killer CellsHampartsoum B Barsoumian, Lalit Batra, Pradeep Shrestha, et al.
Pageof 9